Author

S. P. Webster

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pathology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:imaging· 1

Frequent Co-Authors

N. Z. M. Homer· 2 shared X. Zheng· 2 shared A. Serrels· 1 shared A. Zhang· 1 shared B. R. Walker· 1 shared C. T. Davidson· 1 shared D. J. Mole· 1 shared D. Mole· 1 shared

Activity by Year

2017-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

N. Z. M. Homer

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintAug 4, 2021

11β-HSD1 inhibition does not affect murine tumour angiogenesis but may exert a selective effect on tumour growth by modulating inflammation and fibrosis

C. T. Davidson, E. Miller, M. Muir…·B. R. Walker

This study investigates the effect of 11β-HSD1 inhibition on tumour growth and angiogenesis in murine models, finding increased SCC tumour growth but no effect on angiogenesis.

DOI 10.1101/2021.08.04.455121

mouseproteomics

𝕏 PostBluesky

PathologybioRxivMar 7, 2018

Kynurenine 3-monooxygenase (KMO) is a critical regulator of renal ischemia-reperfusion injury

X. Zheng, A. Zhang, M. Binnie…·D. Mole

This study shows that KMO inhibition protects against renal ischemia-reperfusion injury in mice by reducing renal damage and inflammation.

DOI 10.1038/s12276-019-0210-x

mouseexperimental assay

𝕏 PostBluesky

Pharmacology & ToxicologybioRxivApr 3, 2017

Detecting Drug-Target Binding In Cells Using Fluorescence Activated Cell Sorting Coupled With Mass Spectrometry Analysis

K. Wilson, S. P. Webster, J. P. Iredale…·D. J. Mole

This paper introduces a new method called TAPS to assess drug-target binding in cells, demonstrating its effectiveness with the challenging KMO target.

DOI 10.1088/2050-6120/aa8c60

humanproteomics

𝕏 PostBluesky